Eyal C. Attar - Feb 6, 2025 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Katie Kazem, Attorney-in-Fact
Stock symbol
VOR
Transactions as of
Feb 6, 2025
Transactions value $
-$1,770
Form type
4
Date filed
2/7/2025, 04:35 PM
Previous filing
Feb 5, 2025
Next filing
Feb 12, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VOR Common Stock Tax liability -$1.77K -1.18K -0.89% $1.50 131K Feb 6, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.